The efficacy of this decision is supported by the data presented by two Japanese institutions: The Shizuoka Cancer Center and The National Cancer Center.
La efectividad de esta decisión está soportada con la presentación de datos de dos instituciones japonesas, Shizuoka Cancer Center y el National Center Cancer.